Posts Tagged ‘drug pricing’

Report Card on Our 2022 Trend Predictions

December 31, 2022 — “It’s difficult to make predictions, especially about the future.” With this anonymous piece of wisdom in mind, it still makes sense to take a moment to look back at the trends that we hoped and expected to shape the year we complete today. So here’s a narrative report card on our 2022 trend predictions. You, […]

The Best and Worst of 2022

December 26, 2022 — This has been a good year in so many ways. COVID has moved into the background and people have been reconnecting. We’ve seen remarkable progress in understanding and care for obesity. Of course, we’ve hit some low points that help us to appreciate highlights even more. So here for your consideration is our short list […]

The Most Read Posts on ConscienHealth in 2022

December 16, 2022 — We’re zooming toward the end of 2022, so it’s hard to resist looking back to see which of the posts on ConscienHealth you read the most. We are grateful for the smart and diverse people who take the time to read what we post here. Seeing what captures your attention teaches us a thing or […]

Can We Afford Optimism About Treating Obesity?

November 25, 2022 — “Can’t never could.” This old bit of Southern American wisdom aptly describes one of the startling reactions to impressive progress in obesity treatment – “we can’t do this. It will cost too much.” This reaction has been part of the landscape of obesity care for some time, so it should not be startling. But when […]

Brands That Keep Obesity Separate and Unequal

November 20, 2022 — Fed up. That’s where we are with stories about how people taking semaglutide for obesity are keeping people with diabetes from getting an adequate supply of the drug they need. Fed up, because it’s a stealthy way of expressing implicit bias against people living with obesity. The subtext is that those people don’t really need […]

An Economic Doom Loop for Obesity Care

November 6, 2022 — A pair of thoughts kept floating through the halls of ObesityWeek 2022 and they set up something that seems like an economic doom loop for the future of obesity care. The new drugs for obesity are amazing. But they’re too damn expensive. Professor John Cawley gave an excellent presentation on the economics of obesity that […]

Costly and Effective versus Cheap and Ineffective

September 3, 2022 — ICER – the Institute for Clinical and Economic Review – has released its final report on the effectiveness and value of obesity meds and set a public hearing for September 16. Let’s say it right up front. This private nonprofit is trying to do something that is almost impossibly hard. Making objective sense from the […]

Obesity Drug Prices, Access, Chickens & Eggs

August 12, 2022 — An interesting conversation popped up in a recent session to prepare for the upcoming White House Conference on Hunger Nutrition and Health. It was about obesity drug prices, utilization, and ultimately, access to care. Dariush Mozaffarian was a key speaker at this session organized by the Bipartisan Policy Center. He offered his opinion that you […]

ICER: Seeking Value in Obesity Medicine

July 14, 2022 — We’ve all got our reading assignments. The Institute for Clinical and Economic Review (ICER) has released its draft report on effectiveness and value for the current options in obesity medicine. There’s a lot to process in there. But the bottom line is clear enough. Phentermine/topiramate (Qsymia) offers the best value, says the report. The most […]

Market Forces, Vanity, Obesity, and Diabetes

June 1, 2022 — When “health plans” tell someone seeking treatment for obesity it’s a vanity thing, we are not fooled. They simply don’t want to pay the bill. Health plan? Not really. It’s a lot like car insurance. It pays for a wreck. Not so much for preventing one. Writing in the New York Times today, Gina Kolata […]